Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)

SHA:688076 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,053	11,411	9,583	4,890	8,811	-
Market Cap Growth	5.58%	19.08%	95.95%	-44.50%	-	-
Enterprise Value	14,321	12,107	9,772	4,726	8,238	-
Last Close Price	41.30	36.56	31.40	15.94	28.55	-
PE Ratio	26.16	28.22	58.81	37.88	76.36	-
Forward PE	19.04	20.25	50.65	31.86	30.20	-
PS Ratio	7.09	7.02	9.27	7.51	13.68	-
PB Ratio	4.39	4.25	4.38	2.54	4.87	-
P/TBV Ratio	4.92	4.76	5.04	2.95	5.64	-
P/OCF Ratio	25.21	28.52	27.36	166.95	48.75	-
EV/Sales Ratio	7.78	7.45	9.46	7.26	12.79	-
EV/EBITDA Ratio	17.89	18.27	30.27	27.72	41.45	-
EV/EBIT Ratio	26.15	26.27	51.15	65.84	70.35	-
Debt / Equity Ratio	0.68	0.61	0.41	0.17	0.05	0.26
Debt / EBITDA Ratio	2.53	2.45	2.74	1.86	0.41	1.23
Debt / FCF Ratio	-	-	-	-	-	8.24
Asset Turnover	0.37	0.38	0.34	0.28	0.37	0.43
Inventory Turnover	1.11	1.20	1.27	1.07	1.41	1.66
Quick Ratio	0.72	0.76	1.08	1.26	2.99	0.69
Current Ratio	1.14	1.14	1.54	1.91	4.01	1.28
Return on Equity (ROE)	17.43%	16.41%	8.04%	6.58%	7.84%	13.30%
Return on Assets (ROA)	6.91%	6.68%	3.93%	1.93%	4.15%	6.22%
Return on Capital (ROIC)	7.99%	7.78%	4.48%	2.17%	4.71%	7.28%
Return on Capital Employed (ROCE)	13.80%	13.90%	7.40%	3.60%	6.30%	13.00%
Earnings Yield	3.73%	3.54%	1.70%	2.64%	1.31%	-
FCF Yield	-7.13%	-6.05%	-3.24%	-8.37%	-0.60%	-
Dividend Yield	1.56%	1.76%	0.91%	0.90%	0.38%	-
Payout Ratio	46.24%	29.37%	35.36%	31.43%	5.24%	-
Buyback Yield / Dilution	0.19%	-2.52%	-1.28%	-10.06%	-19.95%	1.06%
Total Shareholder Return	1.75%	-0.76%	-0.37%	-9.17%	-19.58%	1.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.